Noul Co. Ltd.
Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was… Read more
Noul Co. Ltd. (376930) - Total Assets
Latest total assets as of June 2025: ₩29.14 Billion KRW
Based on the latest financial reports, Noul Co. Ltd. (376930) holds total assets worth ₩29.14 Billion KRW as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Noul Co. Ltd. - Total Assets Trend (2019–2024)
This chart illustrates how Noul Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Noul Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Noul Co. Ltd.'s total assets of ₩29.14 Billion consist of 74.8% current assets and 25.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩250.58 Million | 0.7% |
| Accounts Receivable | ₩351.79 Million | 0.9% |
| Inventory | ₩4.16 Billion | 11.0% |
| Property, Plant & Equipment | ₩8.74 Billion | 23.1% |
| Intangible Assets | ₩120.80 Million | 0.3% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Noul Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Noul Co. Ltd.'s current assets represent 74.8% of total assets in 2024, an increase from 65.3% in 2019.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2024, down from 43.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2019.
- Asset Diversification: The largest asset category is property, plant & equipment at 23.1% of total assets.
Noul Co. Ltd. Competitors by Total Assets
Key competitors of Noul Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Noul Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Noul Co. Ltd. generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Noul Co. Ltd. is currently not profitable relative to its asset base.
Noul Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 5.06 | 5.85 |
| Quick Ratio | 1.55 | 4.32 | 5.34 |
| Cash Ratio | 0.00 | 0.00 | 0.04 |
| Working Capital | ₩9.18 Billion | ₩ 20.11 Billion | ₩ 13.68 Billion |
Noul Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Noul Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.84 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -32.0% |
| Total Assets | ₩37.81 Billion |
| Market Capitalization | $31.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Noul Co. Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Noul Co. Ltd.'s assets decreased by 32.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Noul Co. Ltd. (2019–2024)
The table below shows the annual total assets of Noul Co. Ltd. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩37.81 Billion | -31.97% |
| 2023-12-31 | ₩55.58 Billion | +114.99% |
| 2022-12-31 | ₩25.85 Billion | +29.51% |
| 2021-12-31 | ₩19.96 Billion | +28.27% |
| 2020-12-31 | ₩15.56 Billion | +458.12% |
| 2019-12-31 | ₩2.79 Billion | -- |